Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
about
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studiesSynergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.The burden of proof: The current state of atrial fibrillation prevention and treatment trials.Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives.Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial.The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study.The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation.Red Wine, Resveratrol and Atrial Fibrillation.Left Atrial 4D Blood Flow Dynamics and Hemostasis following Electrical Cardioversion of Atrial Fibrillation.Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy.A multi-hospital analysis of predictors of oral anticoagulation prescriptions for patients with actionable atrial fibrillation who attend the emergency department.Mortality in patients with atrial fibrillation and common co-morbidities - a cohort study in primary care.Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis.Diagnostic accuracy of a new algorithm to detect atrial fibrillation in a home blood pressure monitor.Evolutionarily derived networks to inform disease pathways.Association between antidepressant medication use and epithelial ovarian cancer risk: a systematic review and meta-analysis of observational studies.The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation.Impact of post-diagnostic statin use on ovarian cancer mortality: a systematic review and meta-analysis of observational studies.Body mass index, abdominal fatness, and the risk of sudden cardiac death: a systematic review and dose-response meta-analysis of prospective studies.Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.Prognostic significance of preoperative serum albumin in epithelial ovarian cancer patients: a systematic review and dose-response meta-analysis of observational studies.CHA2DS2-VASc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation.How to manage various arrhythmias and sudden cardiac death in the cardiovascular intensive care.Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.Risk Factor Management in Atrial Fibrillation.Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the NetherlandsLiver transplantation and atrial fibrillation: A meta-analysisSelective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births
P2860
Q30234626-11B46F05-FF65-4B31-B79F-EB2D27CDE9FFQ30235583-7364D736-7CDF-41F0-A168-B7C2BA09182AQ30235956-E199260F-76D0-47AA-86AB-6B27B5590B20Q33720574-8AE5B183-93AF-42AE-B37D-C415CDB3601CQ37684261-E11C5383-B51D-4B66-A68E-BB562683363FQ37739398-78F3F45E-49D0-4CC7-9B6F-72435229369BQ38669880-047D1019-843E-4D54-A958-B4C4BD32A186Q39119910-4348B50A-3A8B-471B-8EBD-C5CD3BDD27B3Q39285809-22FAAAD5-6D9C-4A72-8EA2-E3827C1DBE36Q39375528-F4D09D04-28AF-4828-A780-B71117624B2FQ41996339-26D3CF35-8FB2-4647-A871-4B8D4AA0B980Q44824832-244584FA-D27B-498C-824C-D127EE2350CCQ47097420-BA6EB2AF-7880-4F6C-A442-BFFB5FF0AD07Q47097967-B8C47F00-DA4F-42AA-8AFA-9561DBC38F87Q47118426-68FFF8BE-EE18-45FC-83D5-6258137F4212Q47194636-5515FBA1-0A40-4E93-A031-169F4FB0EDE5Q47335254-D333BCC6-FDAD-429E-885C-6D1C12DA6FE7Q47398263-B9BE9420-CC90-4BE7-9A84-63C02AA1398CQ47418143-AC5F0CC8-6F78-47C9-B106-1636A90EB4EDQ47559887-82F38001-455C-40CC-8BC9-2C8B033E3810Q47705606-2E56FB0C-4F4D-4436-8E02-73F780B950B9Q48298179-CFAB7CF3-7BC0-4B8B-A681-F8129EB60DFAQ48325136-3ADC3580-B869-4FBC-BE24-D87CAA91A81BQ49746179-2B929365-8323-4119-A17C-615932CB1E3BQ49907318-07AF5469-7CB9-4412-BBE8-7302ACB962B8Q50126216-DF403FB5-EBF1-4527-8043-B9B42BF23A46Q53273929-8A56DDC9-3749-4BC7-9869-8396FFAE3E48Q53282562-7CF94971-9C1A-4C81-94CE-39E8D9D41D23Q55097624-07614EDB-68E0-4BC2-976D-81D1395E07B8Q55295121-336E8C83-11F0-4111-AD6B-BDEECBF174C6Q55312807-D0DD46EE-551F-484C-80E6-3BBDA1EA9835Q55411533-BFD12647-6D52-4D79-9D30-3BBBCD7D30F8Q57167729-C7A5C65D-20CD-4EA2-B7E8-33076E3FE8A2Q58603834-877616F6-4663-4982-92CF-32B4BD2FA514Q59129888-A71836FF-9C42-4B4F-B80D-F0B77477159C
P2860
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Atrial fibrillation and risks ...... atic review and meta-analysis.
@ast
Atrial fibrillation and risks ...... atic review and meta-analysis.
@en
type
label
Atrial fibrillation and risks ...... atic review and meta-analysis.
@ast
Atrial fibrillation and risks ...... atic review and meta-analysis.
@en
prefLabel
Atrial fibrillation and risks ...... atic review and meta-analysis.
@ast
Atrial fibrillation and risks ...... atic review and meta-analysis.
@en
P2093
P31
P356
P1433
P1476
Atrial fibrillation and risks ...... atic review and meta-analysis.
@en
P2093
Allan J Hsiao
Ayodele Odutayo
Connor A Emdin
Sally Hopewell
P356
10.1136/BMJ.I4482
P407
P577
2016-09-06T00:00:00Z